Literature DB >> 3375778

Folic acid--an innocuous means to reduce plasma homocysteine.

L E Brattström1, B Israelsson, J O Jeppsson, B L Hultberg.   

Abstract

With an improved highly reproducible method, we measured total plasma homocysteine (free plus protein-bound) and related amino acids in the fasting state in healthy subjects, before and after treatment with co-factors for homocysteine metabolism: 1 mg cyanocobalamin (n = 14), 5 mg folic acid (n = 13) or 40 mg pyridoxine hydrochloride (n = 15) daily for 14 days. Cyanocobalamin and pyridoxine hydrochloride had no effects on plasma levels of amino acids, but folic acid had a considerable homocysteine-lowering effect. Total plasma homocysteine was reduced in all but two subjects, from 19.9 +/- 4.4 (mean +/- SEM) to 9.5 +/- 1.0 mumol/l (-52%, p less than 0.01). We propose that folic acid in excess acts by enhancing the remethylation of homocysteine to methionine. The finding confirms a previous report by us. Since homocysteine is considered to be an atherogenic amino acid and recent reports suggest that mild to moderate homocysteinaemia is also associated with premature vascular disease, treatment with folic acid might be of use as prophylaxis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3375778     DOI: 10.3109/00365518809167487

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  24 in total

1.  Nutritional hyperhomocysteinaemia.

Authors:  I V Mohan; G Stansby
Journal:  BMJ       Date:  1999-06-12

2.  The effect of a subnormal vitamin B-6 status on homocysteine metabolism.

Authors:  J B Ubbink; A van der Merwe; R Delport; R H Allen; S P Stabler; R Riezler; W J Vermaak
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.

Authors:  A B Guttormsen; P M Ueland; I Nesthus; O Nygård; J Schneede; S E Vollset; H Refsum
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

4.  Methylenetetrahydrofolate reductase thermolabile variant and human longevity.

Authors:  L Faure-Delanef; I Quéré; J F Chassé; O Guerassimenko; M Lesaulnier; H Bellet; J Zittoun; P Kamoun; D Cohen
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

5.  Atherosclerosis in sickle cell disease - a review.

Authors:  Mohamed A Elsharawy; Khaled M Moghazy; Mohamed A Shawarby
Journal:  Int J Angiol       Date:  2009

6.  Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1998-03-21

7.  Accumulation and distribution of free folic acid content in red beet (Beta vulgaris L.).

Authors:  M Wang; I L Goldman
Journal:  Plant Foods Hum Nutr       Date:  1997       Impact factor: 3.921

Review 8.  The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia.

Authors:  J B Ubbink
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

9.  Effect of losartan with folic acid on plasma homocysteine and vascular ultrastructural changes in spontaneously hypertensive rats.

Authors:  Lihe Zhu; Jiong Yu; Baofu Jia; Feng Zhao; Mengmeng Tang; Lufeng Hu; Feiyan Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

10.  Molecular mechanisms underlying the anti-proliferative and anti-migratory effects of folate on homocysteine-challenged rat aortic smooth muscle cells.

Authors:  Ying Chou; Hui-Chen Lin; Kuan-Chou Chen; Chi-Cheng Chang; Wen-Sen Lee; Shu-Hui Juan
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.